Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness

Morens, David M., Taubenberger, Jeffery K., Fauci, Anthony S.·2008·The Journal of Infectious Diseases

Cited by (1,629)

Items 901–1,000 of 1,629

  1. Effect of network clustering on mutually cooperative coinfections
    Peng-Bi Cui, Francesca Colaiori, Claudio Castellano · 2019 · Physical review. E
  2. Streptococci and Enterococci
    Androulla Efstratiou, Theresa L. Lamagni, Claire E. Turner · 2016 · Elsevier eBooks
  3. Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
    Chunfeng Li, Genhong Cheng · 2020 · Frontiers in Immunology
  4. Antimicrobial Resistance, the COVID-19 Pandemic, and Lessons for the Orthopaedic Community
    Willem‐Jan Metsemakers, Charalampos G. Zalavras, Edward M. Schwarz, Antonia F. Chen, Andrej Trampuž, T. Fintan Moriarty · 2020 · Journal of Bone and Joint Surgery
  5. Dynamic Pneumococcal Genetic Adaptations Support Bacterial Growth and Inflammation during Coinfection with Influenza
    Amanda Pfaff Smith, Lindey C. Lane, Tim van Opijnen, Stacie Woolard, Robert Carter, Amy Iverson, Corinna Burnham, Peter Vogel, Dana Roeber, Gabrielle M. Hochu et al. · 2021 · Infection and Immunity
  6. COVID19 pandemic is a «pandemic» of antimicrobial therapy
    Alexander I. Sinopalnikov · 2021 · Clinical Microbiology and Antimicrobial Chemotherapy
  7. Effectiveness of Pharmacist-Led Brief Educational Intervention for Adherence to the Antibiotics for Lower Respiratory Tract Infections (EATSA) in Post-Conflict Rural Areas of Pakistan: Study Protocol for a Randomized Controlled Trial
    Faiz Ullah Khan, Yu Fang · 2021 · Antibiotics
  8. The Immune Response to Respiratory Viruses: From Start to Memory
    Tom D. Y. Reijnders, Alex R. Schuurman, Tom van der Poll · 2021 · Seminars in Respiratory and Critical Care Medicine
  9. Preventive Measures against Pandemics from the Beginning of Civilization to Nowadays—How Everything Has Remained the Same over the Millennia
    Laura Vitiello, Sara Ilari, Luigi Sansone, Manuel Belli, Mario Cristina, Federica Marcolongo, Carlo Tomino, Lucia Gatta, Vincenzo Mollace, Stefano Bonassi et al. · 2022 · Journal of Clinical Medicine
  10. Viral infectious diseases severity: co-presence of transcriptionally active microbes (TAMs) can play an integral role for disease severity
    Aanchal Yadav, Rajesh Pandey · 2022 · Frontiers in Immunology
  11. Clinical Pathological Characteristics and Management of Acute Respiratory Distress Syndrome Resulting from Influenza A (H1N1) Virus
    Samer Homsi, Natasa Milojkovic, Yamen Homsi · 2010 · Southern Medical Journal
  12. Survey of Japanese infants younger than 3 months who were treated with oseltamivir for influenza: Safety of oseltamivir treatment
    Ichiro Morioka, Shigeaki Nonoyama, Keiko Tanaka‐Taya, Toshiaki Ihara, Norio Sugaya, Ikuya Ueta, Takuji Kumagai, Kenji Okada, Mitsuaki Hosoya, Nobuhiko Okabe et al. · 2012 · Scandinavian Journal of Infectious Diseases
  13. Sex Differences in Influenza Virus Infection, Vaccination, and Therapies
    Jackye Peretz, Olivia J. Hall, Sabra L. Klein · 2015 · Springer eBooks
  14. A comparative evaluation of multiple machine learning approaches for forecasting dengue outbreaks in Bangladesh
    Bowen Liu, Md. Farhad Hossain, Shaheed Hossain · 2025 · Scientific Reports
  15. Exploring Influenza A Virus-Induced Lung Injury and Immune Response Based on Humanized Lung-on-Chip
    Shaoyan Gu, Pan Pan, Jiang Wang, Yinghan Shi, Feng Shi, Yuhan Zhang, Wei Guan, Yan Cao, Haimao Qin, Qingzhong Wang et al. · 2023 · Discovery Medicine
  16. Antibiotic use during influenza infection augments lung eosinophils that impair immunity against secondary bacterial pneumonia
    Marilia Sanches Santos Rizzo Zuttion, Tanyalak Parimon, Stephanie A. Bora, Changfu Yao, Katherine Lagree, Catherine A. Gao, Richard G. Wunderink, Georgios D. Kitsios, Alison M. Morris, Yingze Zhang et al. · 2024 · Journal of Clinical Investigation
  17. RETRACTED: Single-cell RNA-seq reveals the immune response of Co-infection with streptococcus pneumoniae after influenza A virus by a lung-on-chip: The molecular structure and mechanism of tight junction protein ZO-1
    Shaoyan Gu, Wenxuan Xiao, Zhenjun Yu, Xiao Jia, Mingze Sun, Pengfei Zhang, Pan Pan, Lixin Xie · 2025 · International Journal of Biological Macromolecules · Retracted
  18. Pretreatment of Epithelial Cells with Live Streptococcus pneumoniae Has No Detectable Effect on Influenza A Virus Replication In Vitro
    Kang Ouyang, Shireen A. Woodiga, Varun Dwivedi, Carolyn M. Buckwalter, Anirudh K. Singh, Basavaraj Binjawadagi, Jagadish Basayya Hiremath, Cordelia Manickam, Rose Schleappi, Mahesh Khatri et al. · 2014 · PLoS ONE
  19. Two Cases of Influenza B Virus-Related Fatal Fulminant Pneumonia Complicated With Staphylococcus aureus Infection in China Diagnosed Using Next-Generation Sequencing (2018)
    Bing Bai, Hongyan Wang, Meng Li, Xiaoyu Ma, Jinxin Zheng, Qiwen Deng, Zhijian Yu · 2020 · Frontiers in Public Health
  20. Rational use of tocilizumab in COVID-19
    Siddharth Jain, Shefali Sharma · 2020 · Annals of the Rheumatic Diseases
  21. SARS-CoV2 and Co-Infections: A Review of Two Cases
    Sumit Sohal, Guillermo Rodriguez Nava, Ramzy C. Khabbaz · 2020 · Case Reports in Infectious Diseases
  22. Cytokine expression patterns in hospitalized children with Bordetella pertussis, Rhinovirus or co-infection
    Elisabetta Pandolfi, Nadia Panera, Anna Alisi, Emanuela Carloni, Luisa Russo, Ilaria Campagna, Caterina Rizzo, Carlo Concato, Giulia Linardos, Livia Piccioni et al. · 2021 · Scientific Reports
  23. Towards Understanding COVID-19: Molecular Insights, Co-infections, Associated Disorders, and Aging
    Elena L. Paley · 2021 · Journal of Alzheimer s Disease Reports
  24. "Are there any differences in clinical and laboratory findings on admission between H1N1 positive and negative patients with flu-like symptoms?"
    Paul Zarogoulidis, Theodoros C. Constantinidis, Paschalis Steiropoulos, Νικόλαος Παπάνας, Kostas Zarogoulidis, Efstratios S. Maltezos · 2011 · BMC Research Notes
  25. Antibacterial, antifungal, and anti-biofilm effects of sulfamethoxazole-complexes against pulmonary infection agents
    Fallon dos Santos Siqueira, Josiéli Demetrio Siqueira, Laura Bedin Denardi, Kelly Schneider Moreira, Thiago A. L. Burgo, Lenice de Lourenço Marques, Alencar Kolinski Machado, Carolina Bordin Davidson, Otávio Augusto Chaves, Marli Matiko Anraku de Campos et al. · 2022 · Microbial Pathogenesis
  26. Antigen-specific memory Th17 cells promote cross-protection against nontypeable Haemophilus influenzae after mild influenza A virus infection
    Xinyun Zhang, Ying Yang, Shengsen Chen, Wenchao Li, Yong Li, Brian J. Akerley, Linyun Shao, Wenhong Zhang, Hao Shen, Michael C. Abt · 2023 · Mucosal Immunology
  27. Influenza Virus: The Biology of a Changing Virus
    Samira Mubareka, Peter Palese · 2010 · Springer eBooks
  28. Clinical Features of Severe Influenza A (H1N1) Virus Infection
    Yinghu Chen, Shiqiang Shang, Yongmin Tang, Chenmei Zhang, Meiqin Tong, Yuwen Dai · 2012 · The Indian Journal of Pediatrics
  29. The controversy over H5N1 transmissibility research
    David S. Fedson, Steven M. Opal · 2013 · Human Vaccines & Immunotherapeutics
  30. Predictors of Pneumococcal Co-infection for Patients with Pandemic (H1N1) 2009 Influenza
    Mar Masiá · 2011 · Emerging infectious diseases
  31. Factors affecting induction of peripheral IFN-γ recall response to influenza A virus vaccination in pigs
    Zahra F. Olson, Matthew R. Sandbulte, Carine K. Souza, Daniel Roberto Perez, Amy Louise Vincent, Crystal Lynn Loving · 2017 · Veterinary Immunology and Immunopathology
  32. Die Influenza 1918
    Bernd Salzberger, Arno Mohr, Florian Hitzenbichler · 2018 · DMW - Deutsche Medizinische Wochenschrift
  33. Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza
    Kazuyuki Mimura, Soichiro Kimura, Chiaki Kajiwara, Sho Nakakubo, Matthew A Schaller, Yoshikazu Ishii, Theodore J. Standiford, Steven L. Kunkel, Kazuhiro Tateda · 2020 · Microbes and Infection
  34. The Aging Vasculature: Glucose Tolerance, Hypoglycemia and the Role of the Serum Response Factor
    Hazel Aberdeen, Kaela Battles, Ariana Taylor, Jeranae Garner-Donald, Ana Davis-Wilson, Bryan T. Rogers, Candice Cavalier, Emmanuel D. Williams · 2021 · Journal of Cardiovascular Development and Disease
  35. H1N1 influenza – pandemic, 2009
    Janos Osztovits, Csaba Balázs, János Fehér · 2009 · Orvosi Hetilap
  36. A possible relationship of natural killer T cells with humoral immune response to 23-valent pneumococcal polysaccharide vaccine in clinical settings
    Tomomitsu Miyasaka, Tetsuji Aoyagi, 内山 美寧 et al. · 2012 · Vaccine
  37. Contribution of bacterial coinfection to severe influenza infection*
    Daniel S. Chertow · 2012 · Critical Care Medicine
  38. Epidemiology and outcomes of adults with asthma who were hospitalized or died with 2009 pandemic influenza A (H1N1) – California, 2009
    Eva Mortensen, Janice K. Louie, Carol A. Pertowski · 2013 · Influenza and Other Respiratory Viruses
  39. Toll-Like Receptors Dysregulation after Influenza Virus Infection: Insights into Pathogenesis of Subsequent Bacterial Pneumonia
    Yoav Keynan, Keith Raymond Fowke, Terry Blake Ball, Adrienne F. A. Meyers · 2011 · ISRN Pulmonology
  40. Canine influenza virus coinfection with Staphylococcus pseudintermedius enhances bacterial colonization, virus load and clinical presentation in mice
    Dildar Hussain Kalhoro, Shanshan Gao, Xing Xie, Liang Shan, Su Luo, Yanbing Zhao, Yongjie Liu · 2016 · BMC Veterinary Research
  41. A comparative analysis of vaccine administration in urban and non-urban skilled nursing facilities
    Yuan Pu, Veronika Dolar, Azad L. Gucwa · 2016 · BMC Geriatrics
  42. Infectious diseases
    BRYAN CORRIN, Andrew Gordon Nicholson · 2011 · Elsevier eBooks
  43. Increasing the effectivity of the antimicrobial surface of carbon quantum dots-based nanocomposite by atmospheric pressure plasma
    Mária Kováčová, Michal Bodík, Matej Mičušík · 2020 · Clinical Plasma Medicine
  44. Advances in the prevention, management, and treatment of community-acquired pneumonia
    Mathias Wilhelm Pletz, Tobias Welte, Sebastian R. Ott · 2010 · F1000 Medicine Reports
  45. Documentation of indigenous knowledge on medicinal plants used to manage common influenza and related symptoms in Luwero district, central Uganda
    Esther Katuura, Francis Omujal, R. H. Tumusiime · 2016 · Journal of Medicinal Plants Research
  46. Outbreaks of influenza B infection and pneumococcal pneumonia at a mental health facility in Japan
    Yoshitaka Yamazaki, Norihiko Goto, Naoya Iwanami, Mineyuki Hama, Noriko Fujiwara, Yuko Takahashi, Maki Sekiguchi, Bin Chang, Munehiro Yamazaki · 2017 · Journal of Infection and Chemotherapy
  47. Part I: The 1918 Influenza in Missouri: Centennial Remembrance of the Crisis.
    David S. McKinsey, Joel P. McKinsey, Maithe Enriquez · 2019 · PubMed
  48. Evaluation of Bacterial Co-Infections and Antibiotic Resistance in Positive COVID-19 Patients.
    Alpesh M Marua, Nimisha Shethwala, Parth Bhatt, Amar Shah · 2022 · PubMed Central
  49. Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change?
    Sopirala, Madhuri M. · 2021 · Current Opinion in Infectious Diseases
  50. The host transcriptional response to superinfection by influenza A virus and Streptococcus pneumoniae
    Ofir Cohn, Gal Yankovitz, Michal Mandelboim, Naama Peshes‐Yaloz, Rachel Brandes, Eran Bacharach, Irit Gat‐Viks · 2024 · mSystems
  51. Role of the upper airway microbiota in respiratory virus and bacterial pathobiont dynamics in the first year of life
    Matthew S. Kelly, Pixu Shi, Sifelane C. Boiditswe, Emily Qin, Andrew P. Steenhoff, Tiny Mazhani, Mohamed Z. Patel, Coleen K. Cunningham, John Franklin Rawls, Kathy Luinstra et al. · 2025 · Nature Communications
  52. PrtA immunization fails to protect against pulmonary and invasive infection by Streptococcus pneumoniae
    Chen-Fang Hsu, Chen-Hao Hsiao, Shun‐Fu Tseng, Jian-Ru Chen, Yu‐Jou Liao, Sy‐Jou Chen, Chin‐Sheng Lin, Huey‐Kang Sytwu, Yi‐Ping Chuang · 2018 · Respiratory Research
  53. Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx
    Caz Hales, Simon P. Jochems, Rachel Robinson et al. · 2020 · Vaccine
  54. Impact of COVID-19 on Indian Economy- A Review
    Ajay Kumar Poddar, Brijendra Singh Yadav · 2020 · Journal of Humanities and Social Sciences Research
  55. The lung microbiome
    Geraint B. Rogers · 2017 · Emerging Topics in Life Sciences
  56. Stratégies de réduction de l’utilisation des antibiotiques à visée curative en réanimation (adulte et pédiatrique)
    Jean‐Pierre Bédos, Bernard Allaouchiche, Laurence Armand-Lefèvre, Olivier Baldési, Lila Bouadma, Dominique Decré, Samy Figueiredo, Rémy Gauzit, Benoit P. Guery, Nicolas Joram et al. · 2014 · Réanimation
  57. The Health And Economic Impact Of Vaccination With 7-Valent Pneumococcal Vaccine (PCV7) During An Annual Influenza Epidemic And Influenza Pandemic In China
    B. Wang, Ronald Caldwell, Craig S. Roberts, Zhijie An, David R. Strutton, C.I. Chen · 2014 · Value in Health
  58. Biophysical Mechanisms of the Neutralization of Endotoxins by Lipopolyamines
    Diptesh Sil, Lena Heinbockel, Yani Kaconis · 2013 · The Open Biochemistry Journal
  59. Evaluation of chest radiography,lytAreal-time PCR, and other routine tests for diagnosis of community-acquired pneumonia and estimation of possible attributable fraction of pneumococcus in northern Togo
    Alexandre Blake, Berthe‐Marie Njanpop‐Lafourcade, Jean-Noël Telles et al. · 2016 · Epidemiology and Infection
  60. The role of bacterial vaccines in the prevention of influenza mortality
    Keith P. Klugman, Shabir Ahmed Madhi, Amy Sarah Ginsburg, Gail L. Rodgers · 2018 · The Lancet Global Health
  61. The Potential of Influenza HA-Specific Immunity in Mitigating Lethality of Postinfluenza Pneumococcal Infections
    Miriam Klausberger, Ирина Анатольевна Ленева, Irina N. Falynskova, Kirill Vasilev, А. В. Поддубиков, Claudia Lindner, Карташова Надежда Павловна, О. А. Свитич, Marina Stukova, Reingard Maria Grabherr et al. · 2019 · Vaccines
  62. 100 years of influenza research seen through the lens of Covid-19
    Debby Bogaert, David Harold Dockrell · 2020 · Mucosal Immunology
  63. Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection
    Andrea L. Herrera, Christopher M Van Hove, Mary Hanson, James B. Dale, Rodney K. Tweten, Victor C. Huber, Diego G. Diel, Michael S. Chaussee · 2020 · PLoS ONE
  64. Dysregulated Host Responses Underlie 2009 Pandemic Influenza-Methicillin Resistant Staphylococcus aureus Coinfection Pathogenesis at the Alveolar-Capillary Barrier
    Michaela E. Nickol, Sarah M. Lyle, Brendan Dennehy, Jason Kindrachuk · 2020 · Cells
  65. Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019
    Lionel A. Mandell, George G. Zhanel, Coleman Rotstein, John Muscedere, Mark B Loeb, Jennie Johnstone · 2022 · Open Forum Infectious Diseases
  66. Knockdown of FLT4, Nup98, and Nup205 Cellular Genes Effectively Suppresses the Reproduction of Influenza Virus Strain A/WSN/1933 (H1N1) In vitro
    Evgeny Alekseevich Pashkov, Ekaterina Romanovna Korchevaya, Е. Б. Файзулоев et al. · 2022 · Infectious Disorders - Drug Targets
  67. Carbapenem-resistant Klebsiella pneumoniae outbreak in a COVID-19 intensive care unit; a case-control study
    Pınar Ergen, Esra Koçoğlu, Müge Nural et al. · 2022 · Journal of Chemotherapy
  68. Beyond the Pandemic: The Value of Antimicrobial Stewardship
    Souha Sami Kanj, Paula Ramírez, Camilla S Rodrigues · 2022 · Frontiers in Public Health
  69. Inflammation in COVID-19: A Risk for Superinfections
    Mariana Boulos, Tamara Bassal, Layyous Asad, Maamoun Basheer, Nimer Assy · 2022 · COVID
  70. Pneumonia in patients with novel influenza A (H1N1) virus in Southeastern Turkey
    Tacettin Örnek, FUNDA DEMİRTAŞ YALÇIN, Selami Ekin, Şaban Yalçın, Mücahit Yemişen · 2011 · Wiener klinische Wochenschrift
  71. THE AIRWAYS MICROBIAL COMMUNITY COMPOSITION IN HEALTHY INDIVIDUALS AND BRONCHIAL ASTHMA PATIENTS
    S.V. Fedoseenko, Ludmila Mikhailovna Ogorodova, Maria A. Karnaushkina, Evgeny S. Kulikov, Иван Анатольевич Деев, Н. А. Кириллова · 2014 · Annals of the Russian academy of medical sciences
  72. Clinical Year in Review I: Interstitial Lung Disease, Pulmonary Vascular Disease, Pulmonary Infections, and Cardiopulmonary Exercise Testing and Pulmonary Rehabilitation
    Lorraine B. Ware · 2009 · Proceedings of the American Thoracic Society
  73. The (H1N1) 2009 Pandemic Influenza Pneumonia among Adult Patients in Japan
    Yuji Fujikura, Shuichi Kawano, Yuji Kouzaki, Masahiro Shinoda, Yu Hara, Masaharu Shinkai, Soichiro Kanoh, Akihiko Kawana · 2014 · Japanese Journal of Infectious Diseases
  74. Severe A(H1N1)-associated Pneumonia Sequential to Clamidophila pneumoniae Infection in Healthy Subject.
    Andrea Bianco, Roberto Parrella, Vincenzo Esposito · 2011 · PubMed
  75. Influenza Circulation in United States Army Training Camps Before and During the 1918 Influenza Pandemic: Clues to Early Detection of Pandemic Viral Emergence
    Daniel S. Chertow, Rongman Cai, Junfeng Sun, John Grantham, Jeffery K. Taubenberger, David Michael Morens · 2015 · Open Forum Infectious Diseases
  76. Impact of the 2009 influenza A H1N1 pandemic on invasive pneumococcal disease in adults
    María Luisa Pedro-Botet, Joaquín Burgos, Manel Luján, Montserrat Giménez, Jordi Rello, Ana María Planes, Dionisia Fontanals, Irma Casas, Lourdes Mateu, Paola Zuluaga et al. · 2014 · Scandinavian Journal of Infectious Diseases
  77. The 1918–19 influenza pandemic revisited
    Naheed K. Jivraj, A. M. M. Butler · 2013 · The Journal of the Royal College of Physicians of Edinburgh
  78. Positive Contribution of Adjuvanted Influenza Vaccines to the Resolution of Bacterial Superinfections
    Vanessa Zurli, Marilena Gallotta, Marianna Taccone, Emiliano Chiarot, Michela Brazzoli, Federica Corrente, Alessandra Bonci, Daniele Casini, Ennio De Gregorio, Barbara C. Baudner et al. · 2016 · The Journal of Infectious Diseases
  79. Pandemic Risk Modelling
    Dominic Smith · 2017 · Springer eBooks
  80. Mechanisms of Predisposition to Pneumonia
    Anthony J. Infante, Jonathan A. McCullers, Carlos Javier Orihuela · 2015 · Elsevier eBooks
  81. Sialic acid-dependent interaction of group B streptococci with influenza virus-infected cells reveals a novel adherence and invasion mechanism
    Jie Tong, Yuguang Fu, Nai‐Huei Wu, Manfred Rohde, Fandan Meng, Peter Valentin‐Weigand, Georg Herrler · 2017 · Cellular Microbiology
  82. Optimal approaches to preventing severe community-acquired pneumonia
    Giacomo Tanzella, Ana Motos, Denise Battaglini, Andrea Meli, Antoní Torres · 2019 · Expert Review of Respiratory Medicine
  83. Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model
    Claire Nicolas de Lamballerie, Andrés Pizzorno, Julien Fouret, Lea Szpiro, Blandine Padey, Julia Dubois, Thomas Julien, Aurélien Traversier, Victoria Dulière, Pauline Brun et al. · 2020 · Microorganisms
  84. Disease Mongering and the Fear of Pandemic Influenza
    Michael A. Vance · 2010 · International Journal of Health Services
  85. Influenza and bacterial pneumonia
    A M Geddes · 2009 · International Journal of Antimicrobial Agents
  86. Bacterial Coinfection in COVID-19 and Influenza Pneumonia
    Daniel M. Musher · 2021 · American Journal of Respiratory and Critical Care Medicine
  87. Prevalence and Predictors of Concomitant Bacterial Infections in Patients With Respiratory Viruses in Ontario: A Cohort Study
    Yue Wang, Sarah Swayze, Kevin Antoine Brown, Derek R. MacFadden, Samantha M. Lee, Kevin L. Schwartz, Nick Daneman, Bradley J. Langford · 2024 · Open Forum Infectious Diseases
  88. Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections
    Kimberly Freitas Cardoso, Lara Regina Alves de Souza, Beatriz Senra Álvares da Silva Santos, Kétyllen Reis Andrade de Carvalho, Sarah Giarola da Silva Messias, Ana Paula de Faria Gonçalves, Flora Satiko Kano, Pedro Augusto Alves, Marco Antônio Campos, Marcelo Pascoal Xavier et al. · 2024 · npj Vaccines
  89. Understanding the Molecular Interactions Between Influenza A Virus and Streptococcus Proteins in Co-Infection: A Scoping Review
    Askar K. Alshammari, Meshach Maina, Adam Mark Blanchard, Janet M. Daly, Stephen P. Dunham · 2025 · Pathogens
  90. Have Diagnostics, Therapies, and Vaccines Made the Difference in the Pandemic Evolution of COVID-19 in Comparison with “Spanish Flu”?
    Florigio Romano Lista, Mario Stefano Peragallo, Roberto Biselli · 2023 · Pathogens
  91. Increased Fungal Infection Mortality Induced by Concurrent Viral Cellular Manipulations
    Kevin Roe · 2023 · Lung
  92. Co-occurrence of SARS-CoV-2 and Respiratory Pathogens in the Frail Elderly
    Alan J. Wolfe, David Baunoch, Dakun Wang, Ryan Gnewuch, Xinhua Zhao, Thomas Halverson, Patrick Cacdac, Shuguang Huang, Trisha Lauterbach, Natalie Luke · 2020 · JOJ Urology & Nephrology
  93. Pneumococcal colonization and coinfecting respiratory viruses in children under 5 years in Addis Ababa, Ethiopia: a prospective case–control study
    Fiseha Wadilo Wada, Adey Feleke Desta, Meseret Gebre, Wude Mihret, Tamrayehu Seyoum, Kalkidan Melaku, Ashenafi Alemu, Rawleigh Howe, Andargachew Mulu, Adane Mihret · 2024 · Scientific Reports
  94. Triggering Toll-Like Receptor 5 Signaling During Pneumococcal Superinfection Prevents the Selection of Antibiotic Resistance
    Charlotte Costa, Jean‐Claude Sirard, Paddy S. Gibson, Jan‐Willem Veening, Erida Gjini, Mara Baldry · 2024 · The Journal of Infectious Diseases
  95. Human monoclonal antibodies protect against viral-mediated pneumococcal superinfection
    Aaron D. Gingerich, Lauren Mahoney, Anna L. McCormick, Rose J. Miller, Jarrod J. Mousa · 2024 · Frontiers in Immunology
  96. Cell-intrinsic regulation of phagocyte function by interferon lambda during pulmonary viral, bacterial super-infection
    Danielle Antos, Olivia Bartlett Parks, Alexis M. Duray, Nevil Abraham, Joshua J. Michel, Saran Kupul, Rosemary Westcott, John F. Alcorn · 2024 · PLoS Pathogens
  97. The W-Shaped Mortality-Age Distribution of Novel H1N1 Influenza Virus Helps Reconstruct the Second Wave of Pandemic 1918 Spanish Flu
    Lai KY Wing Yiu · 2015 · Journal of Pulmonary & Respiratory Medicine
  98. Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides
    Yulia A. Desheva, Galina Leontieva, Tatiana A. Kramskaya, Tatiana A. Smolonogina, K. B. Grabovskaya, Irina Kiseleva, Руденко Лариса Георгиевна, Alexander N. Suvorov · 2016 · The Open Microbiology Journal
  99. Treating influenza with antibiotics
    Paul Levet, Didier Raoult, Philippe Parola · 2017 · International Journal of Antimicrobial Agents
  100. Pneumococcal nasopharyngeal carriage among Bhutanese children hospitalized with clinical pneumonia: serotypes and viral co-infection
    Sophie Jullien, Ragunath Sharma, Mimi Lhamu Mynak, Desirée Henares, Carmen Muñoz‐Almagro, Quique Bassat · 2020 · BMC Infectious Diseases